100% Quality Guarantee
PhD-Level Technical Support
Biotinylated Anti-CD138 antibody (HDLA010)
Key Features

Anti-CD138 Biotinylated Recombinant Rabbit Monoclonal Antibody (HDLA010)

SKU HDLA010
Product Type Rabbit Monoclonal Antibody
Antibody Type Monoclonal Antibody
Size 100 μg
Reactivity Human
Host Species Rabbit
Antibody Isotype Rabbit Igg
Clone DM45
Synonyms SDC1, Syndecan-1, CD138, SYND1, SDC
$1,548

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Anti-CD138 Biotinylated Recombinant Rabbit Monoclonal Antibody (HDLA010)

The Biotinylated Anti-CD138 Antibody (HDLA010) is a valuable tool for researchers studying CD138, a cell surface protein also known as syndecan-1. This antibody, generated in-house using high-quality materials, is specifically designed to detect and analyze CD138 in various cell types, particularly in the context of immunology and cancer research.CD138 is a key marker for plasma cells and has been linked to multiple myeloma, a type of blood cancer. By targeting CD138 with this biotinylated antibody, researchers can gain insights into the role of CD138 in disease progression and immune function.

The biotinylated format allows for easy detection using streptavidin-based detection systems, making it suitable for a variety of applications such as immunohistochemistry and flow cytometry.By utilizing the Biotinylated Anti-CD138 Antibody (HDLA010), researchers can further our understanding of CD138 biology and potentially pave the way for the development of targeted therapies for diseases associated with CD138 dysregulation.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose